![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, September 26, 2021 6:28:46 PM
I base my decisions on what I know, and how that applies to my experiences.
If a different RAS device company had as much IP as TMDI, and a known commodity like ENOS, with positive references from arguably the world's foremost authority on robot surgery - I'd be invested there instead.
I looked at the potential of the design early in development. Sure I saw chicken cutlets. But I also saw real potential based on the supposition that if TMDI could make THAT, it could be made a lot better. My only flaw was the amount of time and money it took to get this far. Not sorry.
Sure, I understand tech - I was in IT for a good while. I know how to extrapolate. I actually worked on a lot of very cool computers (Onyx, NeXT/Apple, VAX, IBM) back in the day. I recognize unique design, and capabilities when I see it. But, IDK doodly about how an RAS surgical robot should feel, or any subtle nuances regarding the control, or dexterity. All those "things" that make the device great - instead of just ok.
That's recognizing potential and formulating an objective assessment, not pure emotion.
Good luck to all. Regards,BK.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM